ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, giving promising breakthroughs across numerous medical and industrial apps. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, a lot more trusted option for therapeutic use, notably in